Literature DB >> 11581371

Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.

I Vorberg1, K Chan, S A Priola.   

Abstract

A fundamental event in the pathogenesis of transmissible spongiform encephalopathies (TSE) is the conversion of a normal, proteinase K-sensitive, host-encoded protein, PrP-sen, into its protease-resistant isoform, PrP-res. During the formation of PrP-res, PrP-sen undergoes conformational changes that involve an increase of beta-sheet secondary structure. While previous studies in which PrP-sen deletion mutants were expressed in transgenic mice or scrapie-infected cell cultures have identified regions in PrP-sen that are important in the formation of PrP-res, the exact role of PrP-sen secondary structures in the conformational transition of PrP-sen to PrP-res has not yet been defined. We constructed PrP-sen mutants with deletions of the first beta-strand, the second beta-strand, or the first alpha-helix and tested whether these mutants could be converted to PrP-res in both scrapie-infected neuroblastoma cells (Sc(+)-MNB cells) and a cell-free conversion assay. Removal of the second beta-strand or the first alpha-helix significantly altered both processing and the cellular localization of PrP-sen, while deletion of the first beta-strand had no effect on these events. However, all of the mutants significantly inhibited the formation of PrP-res in Sc(+)-MNB cells and had a greatly reduced ability to form protease-resistant PrP in a cell-free assay system. Thus, our results demonstrate that deletion of the beta-strands and the first alpha-helix of PrP-sen can fundamentally affect PrP-res formation and/or PrP-sen processing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581371      PMCID: PMC114577          DOI: 10.1128/JVI.75.21.10024-10032.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Prion protein and species barriers in the transmissible spongiform encephalopathies.

Authors:  S A Priola
Journal:  Biomed Pharmacother       Date:  1999       Impact factor: 6.529

2.  Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies.

Authors:  B Caughey; G J Raymond; D A Kocisko; P T Lansbury
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells.

Authors:  S Lehmann; D A Harris
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

5.  Synthesis and trafficking of prion proteins in cultured cells.

Authors:  A Taraboulos; A J Raeber; D R Borchelt; D Serban; S B Prusiner
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

6.  Foreign PrP expression and scrapie infection in tissue culture cell lines.

Authors:  B Chesebro; K Wehrly; B Caughey; J Nishio; D Ernst; R Race
Journal:  Dev Biol Stand       Date:  1993

7.  Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells.

Authors:  M Rogers; F Yehiely; M Scott; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 8.  Prions and prion proteins.

Authors:  N Stahl; S B Prusiner
Journal:  FASEB J       Date:  1991-10       Impact factor: 5.191

9.  Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection.

Authors:  C F Farquhar; A G Dickinson
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

10.  Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway.

Authors:  B De Strooper; L Umans; F Van Leuven; H Van Den Berghe
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  15 in total

1.  Possible role of region 152-156 in the structural duality of a peptide fragment from sheep prion protein.

Authors:  Simon Megy; Gildas Bertho; Sergey A Kozin; Pascale Debey; Gaston Hui Bon Hoa; Jean-Pierre Girault
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

2.  The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.

Authors:  Eric M Norstrom; James A Mastrianni
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Angelique Igel-Egalon; Clément Barbereau; Jérôme Chapuis; Danica Ciric; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  Prion       Date:  2017-02-08       Impact factor: 3.931

4.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.

Authors:  Christopher F Harrison; Victoria A Lawson; Bradley M Coleman; Yong-Sun Kim; Colin L Masters; Roberto Cappai; Kevin J Barnham; Andrew F Hill
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

Review 6.  Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.

Authors:  Suzette A Priola; Ina Vorberg
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

7.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Effects of the polyene antibiotic derivative MS-8209 on the astrocyte lysosomal system of scrapie-infected hamsters.

Authors:  Vladimir B Grigoriev; Karim T Adjou; Nicole Salès; Steve Simoneau; Jean-Philippe Deslys; Michel Seman; Dominique Dormont; Jean-Guy Fournier
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

9.  Generating Bona Fide Mammalian Prions with Internal Deletions.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Jérôme Chapuis; Danica Ciric; Angelique Igel-Egalon; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 10.  Prion protein misfolding and disease.

Authors:  Roger A Moore; Lara M Taubner; Suzette A Priola
Journal:  Curr Opin Struct Biol       Date:  2009-01-20       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.